FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3736311000001101: Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17669301000001115 Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
66020701000001117 Nivaquine 200mg tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Is a Product containing precisely chloroquine sulfate 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Has active ingredient Chloroquine sulfate false Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Is a Nivaquine true Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Has specific active ingredient Chloroquine sulfate true Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) 28 tablet Is pack of False Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) 28 tablet Has AMP True Nivaquine 200mg tablets (Beacon Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start